Pfizer COVID-19 jab declines faster than AstraZeneca: study
The Hindu
The study is yet to be peer reviewed
The effectiveness of the Pfizer-BioNTech vaccine against COVID-19 declines faster than that of the AstraZeneca jab, according to a new study published on August 19. "Two doses of Pfizer-BioNTech have greater initial effectiveness against new COVID-19 infections, but this declines faster compared with two doses of Oxford-AstraZeneca," researchers at Oxford University said. The study, which has not been peer reviewed, is based on the results of a survey by Britain's Office for National Statistics that carried out PCR tests from December last year to this month on randomly selected households.More Related News

As Gor makes first trip as U.S. Special envoy to South Asia, Delhi watches strategic signals closely
Sergio Gor's inaugural trip as U.S. Special Envoy to South Asia signals strategic U.S. engagement amid regional tensions.

Iran strikes near Israeli nuclear research center as Trump threatens attacks on Iranian power plants
Iran's missile strikes near Israel's nuclear site escalate tensions as Trump threatens retaliation against Iranian power plants.











